Continuing The Trend: Biomet's FCPA Settlement
On March 26, 2012, U.S. medical device maker Biomet Inc. agreed with the U.S. Department of Justice and U.S. Securities and Exchange Commission to settle charges related to alleged bribes paid...To view the full article, register now.
Already a subscriber? Click here to view full article